BLOCKING 17B-HYDROXYSTEROID DEHYDROGENASE TYPE 1 IN ENDOMETRIAL CANCER: A POTENTIAL NOVEL ENDOCRINE THERAPEUTIC APPROACH

被引：0
|
作者：
Cornel, K. M. C. [1 ,2 ]
Konings, G. [2 ,3 ]
Xanthoulea, S. [2 ,3 ]
Delvoux, B. [3 ]
Skowron, M. A. [4 ]
Kooreman, L. [1 ,5 ]
Koskimies, P. [6 ]
Krakstad, C. [7 ,8 ]
Salvesen, H. B. [7 ,8 ]
van Kuijk, K. [1 ,2 ]
Schrooders, Y. J. [1 ,2 ]
Vooijs, M. [1 ,9 ]
Groot, A. J. [1 ,9 ]
Bongers, M. Y. [1 ,2 ]
Kruitwagen, R. R. [1 ,2 ]
Romano, A. [1 ,2 ]
机构：
[1] Maastricht Univ, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, Gynaecol & Obstet, Maastricht, Netherlands
[3] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands
[4] Heinrich Heine Univ Dusseldorf, Urol, Dusseldorf, Germany
[5] Maastricht Univ, Med Ctr, Pathol, Maastricht, Netherlands
[6] Forendo Pharma Ltd, Turku, Finland
[7] Haukeland Hosp, Gynaecol & Obstet, Bergen, Norway
[8] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers, Bergen, Norway
[9] Maastricht Univ, Dept Radiotherapy MAASTRO, Maastricht, Netherlands
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2019年 / 29卷
关键词：
D O I：
10.1136/ijgc-2019-ESGO.560
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP502
引用
收藏
页码：A312 / A313
页数：2
相关论文
共 50 条
  • [21] 11β-Hydroxysteroid dehydrogenase type 1: potential therapeutic target for metabolic syndrome
    Joharapurkar, Amit
    Dhanesha, Nirav
    Shah, Gaurang
    Kharul, Rajendra
    Jain, Mukul
    PHARMACOLOGICAL REPORTS, 2012, 64 (05) : 1055 - 1065
  • [22] INCREASED 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 MRNA LEVEL IS CORRELATED WITH POORER PROGNOSIS IN ENDOMETRIAL CANCER
    Cornel, K. M. C.
    Krakstad, C.
    Delvoux, B.
    Jori, B.
    Salvesen, H. B.
    Bongers, M. Y.
    Kruitwagen, R. F. P. M.
    Romano, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1039 - 1040
  • [23] Increased 17beta-hydroxysteroid dehydrogenase type 1 mRNA level is correlated with poorer prognosis in endometrial cancer
    Cornel, Karlijn
    Krakstad, Camilla
    Delvoux, Bert
    Jori, Balazs
    Salvesen, Helga
    Bongers, Marlies
    Kruitwagen, Roy
    Romano, Andrea
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 59 - 59
  • [24] 17β-hydroxysteroid dehydrogenase type 11 (Pan1b) expression in human prostate cancer
    Nakamura, Y.
    Suzuki, T.
    Arai, Y.
    Sasano, H.
    NEOPLASMA, 2009, 56 (04) : 317 - 320
  • [25] Role of 17 beta-hydroxysteroid dehydrogenase type 1 in endocrine and intracrine estradiol biosynthesis
    Poutanen, M
    Isomaa, V
    Peltoketo, H
    Vihko, R
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 55 (5-6): : 525 - 532
  • [26] Current knowledge of the multifunctional 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1)
    He, Wanhong
    Gauri, Misra
    Li, Tang
    Wang, Ruixuan
    Lin, Sheng-Xiang
    GENE, 2016, 588 (01) : 54 - 61
  • [27] 17β-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer
    Oduwole, OO
    Li, Y
    Isomaa, VV
    Mäntyniemi, A
    Pulkka, AE
    Soini, Y
    Vihko, PT
    CANCER RESEARCH, 2004, 64 (20) : 7604 - 7609
  • [28] Increased 17β-hydroxysteroid dehydrogenase type 1 levels in primary cervical cancer
    Tomaszewska, Agata
    Roszak, Andrzej
    Pawlik, Piotr
    Sajdak, Stefan
    Jagodzinski, Pawel Piotr
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 72 : 179 - 183
  • [29] Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer
    Hilborn, Erik
    Stal, Olle
    Jansson, Agneta
    ONCOTARGET, 2017, 8 (18) : 30552 - 30562
  • [30] 11β-hydroxysteroid dehydrogenase Type 1 as a novel therapeutic target in metabolic and neurodegenerative disease
    Walker, BR
    Seckl, JR
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2003, 7 (06) : 771 - 783
12345